{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:03:06Z","timestamp":1761487386830},"reference-count":43,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1517\/14656566.5.2.237","type":"journal-article","created":{"date-parts":[[2005,5,5]],"date-time":"2005-05-05T01:58:20Z","timestamp":1115258300000},"page":"237-246","source":"Crossref","is-referenced-by-count":16,"title":["The use of fluoroquinolones in the treatment of skin infections"],"prefix":"10.1517","volume":"5","author":[{"given":"Steven J","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dustin G","family":"Zeigler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2005,3,2]]},"reference":[{"key":"CIT0002","unstructured":"BAYER AG: Cipro\u00ae (ciprofloxacin hydrochloride) package insert. Bayer AG, Leverkusen, Germany (2003)."},{"key":"CIT0003","unstructured":"BAYER AG: Avelox\u00ae (moxifloxacin) package insert. Bayer AG, Leverkusen, Germany (2003)."},{"key":"CIT0004","unstructured":"BRISTOL-MYERS SQUIBB: Tequin\u00ae (gatifloxacin) Package Insert. Bristol-Myers Squibb, New York, USA (2003)."},{"key":"CIT0005","unstructured":"ORTHO MCNEIL Pharmaceuticals: Levaquin\u00ae (levofloxacin) package insert. Ortho McNeil Pharmaceuticals, NJ, USA\u2022(2003)."},{"key":"CIT0006","unstructured":"ORTHO MCNEIL Pharmaceuticals:Floxin\u00ae (ofloxacin tablets) package insert.9.Ortho McNeil Pharmaceuticals, NJ, USA(2000)."},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s100960050199","volume":"17","author":"PRENNA M","year":"1998","journal-title":"Eur.Microbial Infect.Dis."},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0732-8893(02)00415-7","volume":"43","author":"KIRBY JT","year":"2002","journal-title":"Diagn. Microbial Infect. Dis."},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.289.7.885","volume":"289","author":"NEUHAUSER MM","year":"2003","journal-title":"JAMA"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/AAC.43.6.1475","volume":"43","author":"GOLDSTEIN EJ","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0924-8579(00)00186-2","volume":"16","author":"SCHAUMANN R","year":"2000","journal-title":"Int. Antimicrob. Agents"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0196-6553(97)90054-7","volume":"25","author":"COHEN FL","year":"1997","journal-title":"Am. Infect. Control."},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1054\/drup.1998.0068","volume":"2","author":"HOOPER DC","year":"1999","journal-title":"Drug Resist. Update"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1128\/AAC.45.10.2755-2764.2001","volume":"45","author":"INCE D","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(85)92510-3","volume":"2","author":"HUMPHREYS H","year":"1985","journal-title":"Lancet"},{"key":"CIT0022","first-page":"883","volume":"45","author":"GILBERT DN","year":"2001","journal-title":"SJ,SLAMA KA et al.: Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, andtrovafloxacin. Antimicrob. Agents Chemother"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00045391-199807000-00002","volume":"5","author":"HERSHOW RC","year":"1998","journal-title":"Am. Thec"},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/JCM.27.2.335-336.1989","volume":"27","author":"SCHAEFLER S","year":"1989","journal-title":"j Clin. Microbial."},{"key":"CIT0026","first-page":"2151","volume":"150","author":"PETERSON LR","year":"1990","journal-title":"Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S. aureus colonization. Arch. Intern. Med."},{"key":"CIT0027","first-page":"800","volume":"50","author":"NO AUTHORS LISTED","year":"2001","journal-title":"Mortal. Wkly Rep."},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.9.2521-2524.2000"},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.37.5.1073","volume":"37","author":"FORREST A","year":"1993","journal-title":"Antimicrob. Agents Chemother"},{"key":"CIT0033","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.43.3.672","volume":"43","author":"LACY MK","year":"1999","journal-title":"Antimicrob.Agents Chemother"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1128\/AAC.46.1.69-74.2002","volume":"46","author":"LISTER PD","year":"2002","journal-title":"Antimicrob. Agents Chemother"},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.47.5.1630-1635.2003","volume":"47","author":"NICOLAU DP","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/AAC.24.5.784","volume":"24","author":"CRUMP B","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/AAC.26.2.208","volume":"26","author":"WISE R LOCKLEY RIVI","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jac\/44.5.701","volume":"44","author":"WISE R","year":"1999","journal-title":"Antimicrob. Chemother"},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AAC.43.10.2345","volume":"43","author":"MULLER M","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/AAC.34.1.78","volume":"34","author":"WARLICH R","year":"1990","journal-title":"Antimicrob. Agents Chemother"},{"key":"CIT0043","first-page":"289","volume":"20","author":"STAHLMANN R","year":"2003","journal-title":"H,OWENS RC Jr et al.: Fluoroquinolones in the elderly: safety considerations. Drugs Aging"},{"key":"CIT0045","first-page":"242","volume":"82","author":"PEREZ-RUVALCABA JA","year":"1987","journal-title":"Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections. Am. J. Med."},{"key":"CIT0046","first-page":"227","volume":"82","author":"PARISH LC","year":"1987","journal-title":"A comparative study of ciprofloxacin and cefotaxime. Am. J. Med."},{"key":"CIT0047","first-page":"432","volume":"6","author":"RAMIREZ-RONDA C","year":"1987","journal-title":"Chemioterapia"},{"key":"CIT0048","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1001\/archinte.1989.00390110127028","volume":"149","author":"GENTRY LO","year":"1989","journal-title":"A multicenter trial. Arch. Intern. Med."},{"key":"CIT0049","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1742-1241.2000.tb10911.x","volume":"54","author":"PARISH LC","year":"2000","journal-title":"Int. J. Clin. Pract."},{"key":"CIT0050","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/00007611-199712000-00006","volume":"90","author":"NICHOLS RL","year":"1997","journal-title":"South. Med. J."},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.8.2358-2362.2001"},{"key":"CIT0055","first-page":"55","volume":"51","author":"GENTRY LO","year":"1993","journal-title":"Cutts"},{"key":"CIT0056","first-page":"675","volume":"21","author":"LIPSKY BA","year":"1999","journal-title":"SCHWARTZ Ret al.: Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections. Clin. Thec"},{"key":"CIT0057","first-page":"230","volume":"82","author":"VALAINIS GT PG, KATNER HP, CORTEZ LM, DALOVISIO JR","year":"1987","journal-title":"Am. .1. Med."},{"key":"CIT0058","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0149-2918(95)80101-4","volume":"17","author":"PANKEY GA","year":"1995","journal-title":"Clin. Titer."},{"key":"CIT0059","first-page":"727","volume":"13","author":"POWERS RD","year":"1991","journal-title":"Clin. Thec"},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0002-9343(87)90063-5","volume":"82","author":"SELF PL ZB, SOLLO D, GENTRY LO","year":"1987","journal-title":"Am. J. Med."}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.5.2.237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T16:14:06Z","timestamp":1706199246000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.5.2.237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,3,2]]},"published-print":{"date-parts":[[2004,2]]}},"alternative-id":["10.1517\/14656566.5.2.237"],"URL":"https:\/\/doi.org\/10.1517\/14656566.5.2.237","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}